World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Seeking a Shorter Path to New Drugs
Keywords:
Tags:
Novartis is developing a whole new system for developing pharmaceutical treatments by putting medical science at the centre of things.
12/11/2007
Novartis' CEO Vasella, and Dr Fishman who heads the global research labs in Cambridge, Massachusetts, are redoing the way the company develops drugs and runs the company. Senior leaders are now medically trained scientists, and Novartis has shed much of the old marketing and sales staff. Drug discovery focusses on Dr. Fishman's approach to go after common molecular pathways and develop medicines for diseases that may be rare, but reveal the knowledge behind addressing all diseases that have that common underlying molecular pathway as the source of the diseases functioning.
Grouped Articles
Novartis Chairman Stresses Need for R&D Investment
Wall Street Journal 03/22/2014
Wall Street Journal 12/11/2007
Wall Street Journal 12/17/2007
BusinessWeek 05/08/2008
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
BusinessWeek 09/04/2008
Research and Development approaches of different pharmaceutical companies.
06/07/2006
As the R&D efforts of pharmaceutical companies become less productive new ways are being explored to develop new drugs for disease.
Grouped Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Research Chief Stirs Up Merck By Seeking Aid From Outsiders
Wall Street Journal 06/07/2006
Firms Study Drugs to Help Avert Diabetes - WSJ.com
Wall Street Journal 10/13/2006
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
BusinessWeek 12/05/2007
Sanofi Overhauls R&D To Help Costs, Pipeline
Wall Street Journal 07/01/2009
Restructuring of pharmaceutical companies
01/16/2007
Changes in the organization structure at western pharmaceutical companies.
Grouped Articles
Wall Street Journal 01/16/2007
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
Wall Street Journal 10/08/2008
Seeking a Shorter Path to New Drugs
New York Times 11/15/2009
Drug Manufacturing Jobs Shrink in the West
New York Times 07/06/2010
Pharmaceutical Research sees big changes.
11/15/2009
Grouped Articles
Seeking a Shorter Path to New Drugs
New York Times 11/15/2009
Glaxo Tries Biotech Model to Spur Drug Innovations
Wall Street Journal 07/01/2010
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us